Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.43 CAD | -0.69% | -10.06% | -20.11% |
Apr. 11 | Oncolytics Biotech Inc. Announces the Submission of a Type C Meeting Request to the FDA | CI |
Apr. 11 | Oncolytics Biotech Down 1.8% In US Premarket As Submits Type C Meeting Request to FDA | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.11% | 78.44M | |
-1.82% | 41.35B | |
+41.93% | 40.38B | |
+2.56% | 39.05B | |
-12.11% | 26.67B | |
+3.09% | 24.07B | |
-24.16% | 18.36B | |
+22.12% | 11.6B | |
-3.74% | 11.68B | |
+7.75% | 11.15B |
- Stock Market
- Equities
- ONC Stock
- News Oncolytics Biotech Inc.
- Oncolytics Biotech : Says Q4 2020 Net Loss Was $9.3 Million, to Report Clinical Biomarker/Safety Data In Breast Cancer in 2021